Annual report pursuant to Section 13 and 15(d)

NON CONTROLLING INTEREST (Details)

v3.24.1
NON CONTROLLING INTEREST (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Net loss attributable to the non-controlling interest $ (3,577) $ (7,419)
BioCorRx Pharmaceuticals, Inc [Member]    
Net loss $ (7,384) $ (18,782)
Average Non-controlling interest percentage of profit/losses 24.20% 24.20%
Net loss attributable to the non-controlling interest $ (1,787) $ (4,545)
Joseph DeSanto MD [Member]    
Net loss $ (5,113) $ (8,211)
Average Non-controlling interest percentage of profit/losses 35.00% 35.00%
Net loss attributable to the non-controlling interest $ (1,790) $ (2,874)